Cost Effectiveness of Interferon-Gamma Release Assay for Tuberculosis Screening of Rheumatoid Arthritis Patients prior to Initiation of Tumor Necrosis Factor-α Antagonist Therapy

Author： Kowada Akiko  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.14, Iss.6, 2010-12, pp. : 367-373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Interferon-Gamma Release Assay for School-Based Tuberculosis Screening

By Kowada Akiko  

Molecular Diagnosis & Therapy, Vol. 16, Iss. 3, 2012-06 ,pp. : 181-190

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Interferon-Gamma Release Assay versus Chest X-Ray for Tuberculosis Screening of BCG-Vaccinated Elderly Populations

By Kowada Akiko  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 4, 2010-08 ,pp. : 229-236

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Interferon-γ Release Assay for Tuberculosis Contact Screening in Japan

By Kowada Akiko  

Molecular Diagnosis & Therapy, Vol. 12, Iss. 4, 2008-01 ,pp. : 235-251

Adis International

Access to resources Recommend Favorite

Necrobiosis lipoidica occurring in a patient with rheumatoid arthritis on concurrent tumor necrosis factor‐α inhibitor therapy

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 11, 2015-11 ,pp. : 1294-1296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Does an interferon-gamma release assay change practice in possible latent tuberculosis?

By Tiernan J.F.  

QJM: An International Journal of Medicine, Vol. 106, Iss. 2, 2013-02 ,pp. : 139-146

Oxford University Press

Access to resources Recommend Favorite